Skip to main content

Activist Oasis suggests three steps to build shareholder value at embattled Kobayashi Pharmaceutical

The Japanese pharmaceutical company is grappling with a scandal, and Oasis thinks it can help right the ship.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.